Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.35 |
| ▸ | EGLN1 | Q9GZT9 | 3/20 | 0.35 |
| ▸ | LDHA | P00338 | 1/20 | 0.35 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.35 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.35 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.35 |
| ▸ | CTH | P32929 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | HMGCR | P04035 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.31 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.31 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | KDM6B | O15054 | 1/20 | 0.31 |
| ▸ | KDM5C | P41229 | 1/20 | 0.31 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2558809 | 0.79 | HMGCR (0.40) | LMNAEGLN1LDHASRRALKBH5 | |
| SCHEMBL15542883 | 0.79 | LMNA (0.38) | LMNAEGLN1LDHASRRALKBH5 | |
| SCHEMBL3964410 | 0.77 | LDHA (0.30) | LMNAEGLN1LDHASRRALKBH5 | |
| SCHEMBL5827218 | 0.76 | LMNA (0.33) | LMNAEGLN1LDHASRRALKBH5 | |
| SCHEMBL496333 | 0.76 | EGLN1 (0.37) | LMNAEGLN1LDHASRRALKBH5 | |
| SCHEMBL345581 | 0.76 | EGLN1 (0.33) | LMNAEGLN1LDHASRRALKBH5 | |
| SCHEMBL7571808 | 0.75 | HMGCR (0.37) | LMNAEGLN1CTHALDH1A1HMGCR | |
| SCHEMBL27023 | 0.75 | — | — | |
| SCHEMBL4816014 | 0.75 | LMNA (0.50) | LMNAEGLN1LDHASRRALKBH5 | |
| Hydrochloric Acid SCHEMBL16057049 | 0.74 | EGLN1 (0.32) | LMNAEGLN1LDHASRRALKBH5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230414760-A1 | PHARMACEUTICAL FORMULATION | ASTRAZENECA UK LIMITED (GB) | 2023-12-28 | — | — | US | claimed |
| EP-4243780-A1 | PHARMACEUTICAL FORMULATION | AstraZeneca UK Limited (GB) | 2023-09-20 | — | — | EP | claimed |
| US-20230126528-A1 | A LIBRARY OF PREFABRICATED MICROPARTICLES AND PRECURSORS THEREOF | BLINK AG (DE) | 2023-04-27 | — | — | US | claimed |
| EP-4078180-A1 | A LIBRARY OF PREFABRICATED MICROPARTICLES AND PRECURSORS THEREOF | Blink AG (DE) | 2022-10-26 | — | — | EP | claimed |
| WO-2022101826-A1 | PHARMACEUTICAL FORMULATION | ASTRAZENECA UK LIMITED (GB) | 2022-05-19 | — | — | WO | claimed |
| WO-2021122563-A1 | A LIBRARY OF PREFABRICATED MICROPARTICLES AND PRECURSORS THEREOF | BLINK AG (DE) | 2021-06-24 | — | — | WO | claimed |
| EP-3839509-A1 | A LIBRARY OF PREFABRICATED MICROPARTICLES AND PRECURSORS THEREOF | Blink AG (DE) | 2021-06-23 | — | — | EP | claimed |
| US-20170100337-A1 | Naltrexone hydrochloride compositions | PURDUE PHARMA LP (US) | 2017-04-13 | — | — | US | claimed |
| CN-102301235-B | Stabilized antibody compositions and methods for stabilizing same | ABBVIE INC | 2014-11-19 | — | — | CN | claimed |
| US-20130338245-A1 | ISOLATION OF NUCLEIC ACIDS | Life Technologies Corporation (US) | 2013-12-19 | — | — | US | claimed |
| WO-2003077867-A2 | NALTREXONE HYDROCHLORIDE COMPOSITIONS | EURO-CELTIQUE, S.A. (LU) | 2003-09-25 | — | — | WO | claimed |
| EP-1345952-A2 | ISOLATION OF NUCLEIC ACIDS | DNA Research Innovations Limited (GB) | 2003-09-24 | — | — | EP | claimed |
| US-20030054395-A1 | Isolation of nucleic acids | Life Technologies Corporation | 2003-03-20 | — | — | US | claimed |
| US-20030008320-A1 | Isolation of nucleic acids | Life Technologies Corporation | 2003-01-09 | — | — | US | claimed |
| WO-2002048164-A2 | ISOLATION OF NUCLEIC ACIDS | DNA RESEARCH INNOVATIONS LIMITED (GB) | 2002-06-20 | — | — | WO | claimed |
| US-20010018513-A1 | Isolation of nucleic acids | Life Technologies Corporation | 2001-08-30 | — | — | US | claimed |
| EP-0527781-A4 | METHODS AND FORMULATIONS FOR STABILIZING FIBROBLAST GROWTH FACTOR | — | 1993-05-26 | — | — | EP | claimed |
| EP-0527781-A1 | METHODS AND FORMULATIONS FOR STABILIZING FIBROBLAST GROWTH FACTOR | SCIOS NOVA INC. (US) | 1993-02-24 | — | — | EP | claimed |
| WO-1991015509-A1 | METHODS AND FORMULATIONS FOR STABILIZING FIBROBLAST GROWTH FACTOR | SCIOSNOVA INC. (US) | 1991-10-17 | — | — | WO | claimed |
| US-4559291-A | DIFFUSION TRANSFER ASSEMBLAGES USING REDOX DYE-RELEASERS, LIGUAND COMPETES FOR METAL TO METAL HYDROXIDE FORMATION | EASTMAN KODAK COMPANY (US) | 1985-12-17 | — | — | US | claimed |